The objectives of development should be integrated into drug policies, particularly in developing countries. Crop eradication should not be carried out unless alternative livelihoods and the infrastructure on which they depend have been put in place first. In addition, the effectiveness of drug policies must be gauged against developmental and human security criteria.
Cannabis has not been reviewed by the WHO since 1934 and much has changed since then. DrugScience produced and presented a report (alongside IDPC) which has now led the WHO to order a cannabis pre-review for CND 2018.
This literature review examines the evidence of effectiveness of different types of drug prevention and education for children and young people in Scotland, principally that which is delivered in schools.
This study aims to provide evidence on international and EU approaches to drug policy, including emerging challenges and focusing on several case study countries. This evidence has been used to identify and develop policy proposals.
The EMCDDA met to discuss how the Council conclusions on the implementation of minimum quality standards in drug demand reduction in the EU can relate to projects at national, European and international level.